Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03728335
Title Enasidenib as Maintenance Therapy in Treating Patients With Acute Myeloid Leukemia With IDH2 Mutation After Donor Stem Cell Transplant
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors City of Hope Medical Center

acute myeloid leukemia



Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST